JP2008542376A - クラスDのβラクタマーゼ阻害剤としての三環系6−アルキリデンペネム類 - Google Patents

クラスDのβラクタマーゼ阻害剤としての三環系6−アルキリデンペネム類 Download PDF

Info

Publication number
JP2008542376A
JP2008542376A JP2008514712A JP2008514712A JP2008542376A JP 2008542376 A JP2008542376 A JP 2008542376A JP 2008514712 A JP2008514712 A JP 2008514712A JP 2008514712 A JP2008514712 A JP 2008514712A JP 2008542376 A JP2008542376 A JP 2008542376A
Authority
JP
Japan
Prior art keywords
optionally substituted
oxo
thia
azabicyclo
ene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008514712A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008542376A5 (enExample
Inventor
タレク スハイル マンスール,
アラナパカム ムドゥンバイ ベンカテサン,
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth LLC filed Critical Wyeth LLC
Publication of JP2008542376A publication Critical patent/JP2008542376A/ja
Publication of JP2008542376A5 publication Critical patent/JP2008542376A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/424Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP2008514712A 2005-06-01 2006-05-25 クラスDのβラクタマーゼ阻害剤としての三環系6−アルキリデンペネム類 Withdrawn JP2008542376A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68622105P 2005-06-01 2005-06-01
PCT/US2006/020410 WO2007030166A2 (en) 2005-06-01 2006-05-25 TRICYCLIC 6-ALKYLIDENE-PENEMS AS CLASS-D β-LACTAMASES INHIBITORS

Publications (2)

Publication Number Publication Date
JP2008542376A true JP2008542376A (ja) 2008-11-27
JP2008542376A5 JP2008542376A5 (enExample) 2009-06-04

Family

ID=37836305

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008514712A Withdrawn JP2008542376A (ja) 2005-06-01 2006-05-25 クラスDのβラクタマーゼ阻害剤としての三環系6−アルキリデンペネム類

Country Status (14)

Country Link
US (1) US20060276446A1 (enExample)
EP (1) EP1885358A2 (enExample)
JP (1) JP2008542376A (enExample)
CN (1) CN101189010A (enExample)
AR (1) AR054467A1 (enExample)
AU (1) AU2006287938A1 (enExample)
BR (1) BRPI0611491A2 (enExample)
CA (1) CA2610478A1 (enExample)
GT (1) GT200600235A (enExample)
MX (1) MX2007015173A (enExample)
PE (1) PE20070010A1 (enExample)
SV (1) SV2007002555A (enExample)
TW (1) TW200716104A (enExample)
WO (1) WO2007030166A2 (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009517029A (ja) * 2005-11-23 2009-04-30 ザ・コカ−コーラ・カンパニー 食物繊維を含む高甘味度甘味料組成物及びこれにより甘味を付与された組成物
JP2009517032A (ja) * 2005-11-23 2009-04-30 ザ・コカ−コーラ・カンパニー プロバイオティクス/プレバイオティクスを含む高甘味度甘味料組成物及びこれにより甘味を付与された組成物
WO2010098332A1 (ja) * 2009-02-26 2010-09-02 エーザイ・アール・アンド・ディー・マネジメント株式会社 多環式化合物の製造法およびその中間体
US8945652B2 (en) 2005-11-23 2015-02-03 The Coca-Cola Company High-potency sweetener for weight management and compositions sweetened therewith

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR039774A1 (es) * 2002-05-01 2005-03-02 Wyeth Corp 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas
AR039475A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa
TW200716102A (en) * 2005-06-01 2007-05-01 Wyeth Corp Bicyclic 6-alkylidene-penems as class-D β -lactamases inhibitors
US20110288063A1 (en) * 2010-05-19 2011-11-24 Naeja Pharmaceutical Inc. Novel fused bridged bicyclic heteroaryl substituted 6-alkylidene penems as potent beta-lactamase inhibitors
CN104341345B (zh) * 2014-10-24 2016-03-23 海门海康生物医药科技有限公司 一种2-甲氧基-6-酮-5,6,7,8-四氢喹啉的合成方法
WO2020179859A1 (ja) 2019-03-06 2020-09-10 第一三共株式会社 ピロロピラゾール誘導体

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2206502T3 (es) * 1994-04-25 2004-05-16 Smithkline Beecham Plc Formulaciones farmaceuticas que contienen un penem inhibidor de beta-lactamasa en combinacion con un antibiotico de beta-lactama y su uso en el tratamiento de infecciones bacterianas.
US20040132706A1 (en) * 2001-10-05 2004-07-08 Daniela Salvemini Composition comprising a catalyst for the dismutation of superoxide and use of the composition for preventing and treating hypotension
US20040132708A1 (en) * 2002-05-01 2004-07-08 Wyeth Process for preparing 6-alkylidene penem derivatives
AR039774A1 (es) * 2002-05-01 2005-03-02 Wyeth Corp 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas
AR039476A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp Proceso para preparar derivados de 6-alquiliden penem
AR039475A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa
TW200716102A (en) * 2005-06-01 2007-05-01 Wyeth Corp Bicyclic 6-alkylidene-penems as class-D β -lactamases inhibitors

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009517029A (ja) * 2005-11-23 2009-04-30 ザ・コカ−コーラ・カンパニー 食物繊維を含む高甘味度甘味料組成物及びこれにより甘味を付与された組成物
JP2009517032A (ja) * 2005-11-23 2009-04-30 ザ・コカ−コーラ・カンパニー プロバイオティクス/プレバイオティクスを含む高甘味度甘味料組成物及びこれにより甘味を付与された組成物
US8512789B2 (en) 2005-11-23 2013-08-20 The Coca-Cola Company High-potency sweetener composition with dietary fiber and compositions sweetened therewith
US8524304B2 (en) 2005-11-23 2013-09-03 The Coca-Cola Company High-potency sweetener composition with probiotics/prebiotics and compositions sweetened therewith
US8945652B2 (en) 2005-11-23 2015-02-03 The Coca-Cola Company High-potency sweetener for weight management and compositions sweetened therewith
WO2010098332A1 (ja) * 2009-02-26 2010-09-02 エーザイ・アール・アンド・ディー・マネジメント株式会社 多環式化合物の製造法およびその中間体

Also Published As

Publication number Publication date
WO2007030166A2 (en) 2007-03-15
WO2007030166A3 (en) 2007-05-24
EP1885358A2 (en) 2008-02-13
GT200600235A (es) 2007-03-29
US20060276446A1 (en) 2006-12-07
SV2007002555A (es) 2007-02-02
MX2007015173A (es) 2008-02-15
AU2006287938A1 (en) 2007-03-15
AR054467A1 (es) 2007-06-27
CN101189010A (zh) 2008-05-28
CA2610478A1 (en) 2007-03-15
TW200716104A (en) 2007-05-01
BRPI0611491A2 (pt) 2010-12-21
PE20070010A1 (es) 2007-01-12

Similar Documents

Publication Publication Date Title
US7691842B2 (en) Tricyclic 6-alkylidene-penems as β-lactamase inhibitors
US7812014B2 (en) Bicyclic 6-alkylidene-penems as β-lactamase inhibitors
JP2008542376A (ja) クラスDのβラクタマーゼ阻害剤としての三環系6−アルキリデンペネム類
US20040132708A1 (en) Process for preparing 6-alkylidene penem derivatives
US20060276445A1 (en) Bicyclic 6-alkylidene-penems as class-D beta-lactamases inhibitors
US20070232582A1 (en) 4-substituted or unsubtituted-7-hydro-1,4-thiazepine-7-[bicyclic or tricyclic heteroaryl] substituted-3,6-dicarboxylic acid derivatives as beta-lactamase inhibitors
US7229983B2 (en) 4-substituted or unsubstituted-7-hydro-1,4-thiazepine-7-[bicyclic or tricyclic heteroaryl] substituted-3,6-dicarboxylic acid derivatives as β-lactamase inhibitors
HK1124064A (en) Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090414

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090414

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100401

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20100414